Literature DB >> 2153513

Alterations of glucose metabolism in chronic liver disease.

C Del Vecchio Blanco1, S Gentile, R Marmo, L Carbone, M Coltorti.   

Abstract

The prevalence of glucose intolerance has been studied by oral glucose tolerance test in 670 patients affected by chronic liver disease. The glycometabolic status was evaluated by criteria given by WHO in 1980. Sixty-nine subjects appeared to be affected by chronic persistent hepatitis and 140 by chronic active hepatitis. In these patients the prevalence of diabetic responses (DR) did not differ much from that of the general population in our geographic area. In contrast, a markedly higher frequency of DR appeared in a cirrhotic group of 401 patients compared to non-cirrhotic subjects. The cirrhotics, divided according to different disease stages, showed a higher DR frequency in decompensated patients than in well compensated patients, the prevalence reaching 63% in the former subgroup. The coincident presence of hepatocarcinoma - documented in 60 other cirrhotic patients - does not modify the prevalence of diabetes. Other risk factors for diabetes such as age, sex, and family history have been considered. Our results suggest that: (1) all these factors seem not to play a major role in the pathogenesis of alterations of glucose metabolism in patients suffering from chronic liver disease, and therefore (2) liver cirrhosis by itself might be a risk factor in the disturbance of glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153513     DOI: 10.1016/0168-8227(90)90093-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  15 in total

1.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

Review 2.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

3.  Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose.

Authors:  Y Kihara; Y Ogami; A Tabaru; H Unoki; M Otsuki
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

4.  Glycemic Control in Patients Undergoing Treatment With Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir for Chronic Hepatitis C Infection.

Authors:  Xenia Bacinschi; Adriana Mercan-Stanciu; Letitia Toma; Anca Zgura; Nicolae Bacalbasa; Chen-Peng Ifrim; Camelia Diaconu; Laura Iliescu; Radu Valeriu Toma
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 5.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

6.  Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects.

Authors:  B Balkau; E Eschwège; A Fontbonne; J R Claude; J M Warnet
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

7.  Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage.

Authors:  Hyo Keun Jeon; Moon Young Kim; Soon Koo Baik; Hong Jun Park; Hoon Choi; So Yeon Park; Bo Ra Kim; Jin Heon Hong; Ki Won Jo; Seung Yong Shin; Jung Min Kim; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Young Ju Kim; Seung Hwan Cha; Dong Joon Kim; Ki Tae Suk; Gab Jin Cheon; Young Don Kim; Dae Hee Choi; Sung Joon Lee
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

8.  Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.

Authors:  Diego García-Compeán; Joel Omar Jáquez-Quintana; Fernando Javier Lavalle-González; José Alberto González-González; Linda Elsa Muñoz-Espinosa; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease.

Authors:  Seyed M Alavian; Behzad Hajarizadeh; Fariborz Nematizadeh; Bagher Larijani
Journal:  BMC Endocr Disord       Date:  2004-11-19       Impact factor: 2.763

10.  Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria.

Authors:  James A Ndako; Georgebest O Echeonwu; Nathaniel N Shidali; Iliyasu A Bichi; Grace A Paul; Ema Onovoh; Lilian A Okeke
Journal:  Virol J       Date:  2009-07-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.